This article summarizes the outcomes of clinical trials and the Chinese newest guidelines for management of patients with acute ST-segment elevation myocardial infarction published in 2010, the Chinese newest guidelines for management of patients with non-ST-segment elevation acute coronary syndrome published in 2012, and the Chinese newest guidelines for management of patients with stable angina published in 2007 and the application of the angiotensin-converting enzyme inhibitors in coronary artery diseases including acute ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction and stable angina, with focus on the current status in China.%本文以临床试验和中国2010年发表的《急性ST段抬高型心肌梗死诊断和治疗指南》、2012年发表的《非ST段抬高的急性冠脉综合征诊断和治疗指南》和2007年发表的《稳定型心绞痛诊断与治疗指南》为依据，从急性ST段抬高型心肌梗死、非ST段抬高的心肌梗死和稳定型心绞痛3个方面来概述血管紧张素转化酶抑制剂在冠心病治疗中的应用，同时通过一项调查研究给出此类药物在我国冠心病患者中的应用现况。
展开▼
